For intravenous use only .
Indication | Dose | Initial Infusion Rate | Maximum Infusion Rate (as tolerated) |
PI | 300-600 mg/kg (3-6 mL/kg)every 3-4 weeks | 1 mg/kg/min (0.01 mL/kg/min) | 14 mg/kg/min (0.14 mL/kg/min) |
Chronic ITP in adults | 2 g/kg (20 mL/kg), divided into 2 daily doses of 1 g/kg (10 mL/kg) given on 2 consecutive days | 1 mg/kg/min (0.01 mL/kg/min) | 8 mg/kg/min (0.08 mL/kg/min) |
CIDP in adults | Loading dose: 2 g/kg (20 mL/kg), divided into 2 daily doses of 1 g/kg (10 mL/kg) given on 2 consecutive days Maintenance dose: 1-2 g/kg (10-20 mL/kg) every 3 weeks divided in 2 doses given over 2 consecutive days | 1 mg/kg/min (0.01 mL/kg/min) | 12 mg/kg/min (0.12 mL/kg/min) |
•Ensure that patients with pre-existing renal insufficiency are not volume depleted; discontinue PANZYGA if renal function deteriorates .
•For patients at risk of renal dysfunction or thrombotic events, administer PANZYGA at the minimum dose and infusion rate practicable .